NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/12/2024
Back to search
Official data from USPTO
LYMPHOTRACK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LYMPHOTRACK
ST13
US500000085054965Class
1, 5
Filing
85054965
Registration
4511019
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
04/12/2024
Trademark type
Word
Nice classes
1, 5
Filing date
06/04/2010
Registration date
04/08/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/12/2024
Last transaction
04/12/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/18/2005
First use in commerce
04/10/2006
Drawing code
4
Owner type
03
Owner location
SAN DIEGO, CA, US
Examiner
ORTIGA PALMER, RAMONA
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
INVIVOSCRIBE, INC.
Invivoscribe Technologies, Inc.
Representatives
Sarah W. Matthews Dentons Durham Jones Pinegar
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for scientific and research usebuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for researchclinical or medical laboratory use
Class 5
Assays for the treatment or diagnosis of disease; medical diagnostic reagentsbuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic kits comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatmentmonitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for researchclinical and medical use
Publications
History of USPTO decisions and trademark events.
63 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/12/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/11/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/01/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/08/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/30/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/30/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2020
E815
TEAS SECTION 8 & 15 RECEIVED
09/24/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/08/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/05/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/28/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/28/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/06/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/05/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/25/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/25/2014
IUAF
USE AMENDMENT FILED
01/30/2014
EISU
TEAS STATEMENT OF USE RECEIVED
01/30/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/07/2013
EX3G
SOU EXTENSION 3 GRANTED
08/06/2013
EXT3
SOU EXTENSION 3 FILED
07/30/2013
EEXT
SOU TEAS EXTENSION RECEIVED
07/30/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/27/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/27/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2013
EX2G
SOU EXTENSION 2 GRANTED
02/11/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/11/2013
EXT2
SOU EXTENSION 2 FILED
01/30/2013
EEXT
SOU TEAS EXTENSION RECEIVED
01/30/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/01/2012
EX1G
SOU EXTENSION 1 GRANTED
07/30/2012
EXT1
SOU EXTENSION 1 FILED
07/30/2012
EEXT
SOU TEAS EXTENSION RECEIVED
07/30/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/31/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/06/2011
PUBO
PUBLISHED FOR OPPOSITION
12/06/2011
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/16/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/02/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/30/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/18/2011
GNRT
NON-FINAL ACTION E-MAILED
05/18/2011
CNRT
NON-FINAL ACTION WRITTEN
05/18/2011
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/06/2011
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/22/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/09/2011
ALIE
ASSIGNED TO LIE
04/09/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/08/2010
GNRT
NON-FINAL ACTION E-MAILED
09/08/2010
CNRT
NON-FINAL ACTION WRITTEN
09/08/2010
DOCK
ASSIGNED TO EXAMINER
08/26/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
06/10/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/09/2010
NWAP
NEW APPLICATION ENTERED
06/08/2010
Continuous trademark protection
Get notified about every new filing that threatens LYMPHOTRACK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.